José Luis Ordoñez-Librado, “L-DOPA/Capsazepine or L-DOPA/Rimonabant Co-Administration in an Experimental Parkinson Disease Model: Behavioral and Cellular Consequences”, IDMMR-V5, pp. 35–60, Feb. 2022.